Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1991;102:232–244.

Erythropoietin: from bench to bedside.

J L Spivak 1
PMCID: PMC2376643  PMID: 2130563

Abstract

Erythropoietin is unique amongst the hematopoietic growth factors since it is the only one which behaves like a hormone. The development of sensitive immunoassays for erythropoietin have provided an opportunity to examine its physiology more closely than ever before. Although the classical inverse-linear correlation between erythropoietin and hemoglobin has been amply confirmed, it has also become apparent that this relationship is tightly regulated and is only apparent below a threshold hemoglobin and not fully operative within the normal range of hemoglobin values. Certain disease states blunt the response of erythropoietin-producing cells to anemia, and in some cases this appears to be due to a resetting of the threshold for response while in others there may be a dichotomy between activation of the machinery for erythropoietin gene expression and net protein synthesis. The tight regulation of erythropoietin production may be directed in part at preventing explosive increases in the red cell mass and in part may conform to the actual demands of erythroid progenitor cells for the hormone, since, at least in vitro, erythropoietin effects these progenitor cells differently according to their stage of maturation and sustained high levels of the hormone are not necessary for certain of the desired effects.

Full text

PDF
232

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbrecht P. H., Littell J. K. Plasma erythropoietin in men and mice during acclimatization to different altitudes. J Appl Physiol. 1972 Jan;32(1):54–58. doi: 10.1152/jappl.1972.32.1.54. [DOI] [PubMed] [Google Scholar]
  2. Adamson J. W. The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation. Blood. 1968 Oct;32(4):597–609. [PubMed] [Google Scholar]
  3. Baer A. N., Dessypris E. N., Goldwasser E., Krantz S. B. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol. 1987 Aug;66(4):559–564. doi: 10.1111/j.1365-2141.1987.tb01344.x. [DOI] [PubMed] [Google Scholar]
  4. Chandra M., Clemons G. K., McVicar M. I. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure. J Pediatr. 1988 Dec;113(6):1015–1021. doi: 10.1016/s0022-3476(88)80573-0. [DOI] [PubMed] [Google Scholar]
  5. Chandra M., Clemons G. K., McVicar M., Wilkes B., Bluestone P. A., Mailloux L. U., Mossey R. T. Serum erythropoietin levels and hematocrit in end-stage renal disease: influence of the mode of dialysis. Am J Kidney Dis. 1988 Sep;12(3):208–213. doi: 10.1016/s0272-6386(88)80123-9. [DOI] [PubMed] [Google Scholar]
  6. Egrie J. C., Cotes P. M., Lane J., Gaines Das R. E., Tam R. C. Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods. 1987 May 20;99(2):235–241. doi: 10.1016/0022-1759(87)90133-5. [DOI] [PubMed] [Google Scholar]
  7. Embury S. H., Garcia J. F., Mohandas N., Pennathur-Das R., Clark M. R. Effects of oxygen inhalation on endogenous erythropoietin kinetics, erythropoiesis, and properties of blood cells in sickle-cell anemia. N Engl J Med. 1984 Aug 2;311(5):291–295. doi: 10.1056/NEJM198408023110504. [DOI] [PubMed] [Google Scholar]
  8. Eschbach J. W., Egrie J. C., Downing M. R., Browne J. K., Adamson J. W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987 Jan 8;316(2):73–78. doi: 10.1056/NEJM198701083160203. [DOI] [PubMed] [Google Scholar]
  9. Fischl M., Galpin J. E., Levine J. D., Groopman J. E., Henry D. H., Kennedy P., Miles S., Robbins W., Starrett B., Zalusky R. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med. 1990 May 24;322(21):1488–1493. doi: 10.1056/NEJM199005243222103. [DOI] [PubMed] [Google Scholar]
  10. Flaharty K. K., Caro J., Erslev A., Whalen J. J., Morris E. M., Bjornsson T. D., Vlasses P. H. Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men. Clin Pharmacol Ther. 1990 May;47(5):557–564. doi: 10.1038/clpt.1990.76. [DOI] [PubMed] [Google Scholar]
  11. Fried W., Barone-Varelas J. Regulation of the plasma erythropoietin level in hypoxic rats. Exp Hematol. 1984 Oct;12(9):706–711. [PubMed] [Google Scholar]
  12. Goldberg M. A., Dunning S. P., Bunn H. F. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science. 1988 Dec 9;242(4884):1412–1415. doi: 10.1126/science.2849206. [DOI] [PubMed] [Google Scholar]
  13. Goodnough L. T., Brittenham G. M. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med. 1990 Jan;115(1):28–35. [PubMed] [Google Scholar]
  14. Goodnough L. T., Rudnick S., Price T. H., Ballas S. K., Collins M. L., Crowley J. P., Kosmin M., Kruskall M. S., Lenes B. A., Menitove J. E. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med. 1989 Oct 26;321(17):1163–1168. doi: 10.1056/NEJM198910263211705. [DOI] [PubMed] [Google Scholar]
  15. Hochberg M. C., Arnold C. M., Hogans B. B., Spivak J. L. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis Rheum. 1988 Oct;31(10):1318–1321. doi: 10.1002/art.1780311016. [DOI] [PubMed] [Google Scholar]
  16. Hågå P., Cotes P. M., Till J. A., Minty B. D., Shinebourne E. A. Serum immunoreactive erythropoietin in children with cyanotic and acyanotic congenital heart disease. Blood. 1987 Sep;70(3):822–826. [PubMed] [Google Scholar]
  17. Jacobs K., Shoemaker C., Rudersdorf R., Neill S. D., Kaufman R. J., Mufson A., Seehra J., Jones S. S., Hewick R., Fritsch E. F. Isolation and characterization of genomic and cDNA clones of human erythropoietin. 1985 Feb 28-Mar 6Nature. 313(6005):806–810. doi: 10.1038/313806a0. [DOI] [PubMed] [Google Scholar]
  18. Jelkmann W. Temporal pattern of erythropoietin titers in kidney tissue during hypoxic hypoxia. Pflugers Arch. 1982 Mar;393(1):88–91. doi: 10.1007/BF00582397. [DOI] [PubMed] [Google Scholar]
  19. Kickler T. S., Spivak J. L. Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA. 1988 Jul 1;260(1):65–67. [PubMed] [Google Scholar]
  20. Kilbridge T. M., Fried W., Heller P. The mechanism by which plethora suppresses erythropoiesis. Blood. 1969 Jan;33(1):104–113. [PubMed] [Google Scholar]
  21. Koury M. J., Bondurant M. C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 1990 Apr 20;248(4953):378–381. doi: 10.1126/science.2326648. [DOI] [PubMed] [Google Scholar]
  22. Koury S. T., Koury M. J., Bondurant M. C., Caro J., Graber S. E. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood. 1989 Aug 1;74(2):645–651. [PubMed] [Google Scholar]
  23. Lin F. K., Suggs S., Lin C. H., Browne J. K., Smalling R., Egrie J. C., Chen K. K., Fox G. M., Martin F., Stabinsky Z. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7580–7584. doi: 10.1073/pnas.82.22.7580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ludwig H., Fritz E., Kotzmann H., Höcker P., Gisslinger H., Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med. 1990 Jun 14;322(24):1693–1699. doi: 10.1056/NEJM199006143222402. [DOI] [PubMed] [Google Scholar]
  25. Macdougall I. C., Roberts D. E., Neubert P., Dharmasena A. D., Coles G. A., Williams J. D. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lancet. 1989 Feb 25;1(8635):425–427. doi: 10.1016/s0140-6736(89)90014-7. [DOI] [PubMed] [Google Scholar]
  26. Macdougall I. C., Roberts D. E., Neubert P., Dharmasena A. D., Coles G. A., Williams J. D. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lancet. 1989 Feb 25;1(8635):425–427. doi: 10.1016/s0140-6736(89)90014-7. [DOI] [PubMed] [Google Scholar]
  27. McGonigle R. J., Wallin J. D., Shadduck R. K., Fisher J. W. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 1984 Feb;25(2):437–444. doi: 10.1038/ki.1984.36. [DOI] [PubMed] [Google Scholar]
  28. McKeon J. L., Saunders N. A., Murree-Allen K., Olson L. G., Gyulay S., Dickeson J., Houghton A., Wlodarczyk J., Hensley M. J. Urinary uric acid:creatinine ratio, serum erythropoietin, and blood 2,3-diphosphoglycerate in patients with obstructive sleep apnea. Am Rev Respir Dis. 1990 Jul;142(1):8–13. doi: 10.1164/ajrccm/142.1.8. [DOI] [PubMed] [Google Scholar]
  29. Milledge J. S., Cotes P. M. Serum erythropoietin in humans at high altitude and its relation to plasma renin. J Appl Physiol (1985) 1985 Aug;59(2):360–364. doi: 10.1152/jappl.1985.59.2.360. [DOI] [PubMed] [Google Scholar]
  30. Miller C. B., Jones R. J., Piantadosi S., Abeloff M. D., Spivak J. L. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med. 1990 Jun 14;322(24):1689–1692. doi: 10.1056/NEJM199006143222401. [DOI] [PubMed] [Google Scholar]
  31. Miyake T., Kung C. K., Goldwasser E. Purification of human erythropoietin. J Biol Chem. 1977 Aug 10;252(15):5558–5564. [PubMed] [Google Scholar]
  32. Nishimura M., Inoue M., Nakano T., Nishikawa T., Miyamoto M., Kobayashi T., Kitamura Y. Beige rat: a new animal model of Chediak-Higashi syndrome. Blood. 1989 Jul;74(1):270–273. [PubMed] [Google Scholar]
  33. Oster W., Herrmann F., Gamm H., Zeile G., Lindemann A., Müller G., Brune T., Kraemer H. P., Mertelsmann R. Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol. 1990 Jun;8(6):956–962. doi: 10.1200/JCO.1990.8.6.956. [DOI] [PubMed] [Google Scholar]
  34. Pincus T., Olsen N. J., Russell I. J., Wolfe F., Harris E. R., Schnitzer T. J., Boccagno J. A., Krantz S. B. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med. 1990 Aug;89(2):161–168. doi: 10.1016/0002-9343(90)90294-n. [DOI] [PubMed] [Google Scholar]
  35. REISSMANN K. R. Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood. 1950 Apr;5(4):372–380. [PubMed] [Google Scholar]
  36. Recny M. A., Scoble H. A., Kim Y. Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin. J Biol Chem. 1987 Dec 15;262(35):17156–17163. [PubMed] [Google Scholar]
  37. Sawada K., Krantz S. B., Dai C. H., Koury S. T., Horn S. T., Glick A. D., Civin C. I. Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol. 1990 Feb;142(2):219–230. doi: 10.1002/jcp.1041420202. [DOI] [PubMed] [Google Scholar]
  38. Schooley J. C., Mahlmann L. J. Evidence for the De Novo synthesis of erythropoietin in hypoxic rats. Blood. 1972 Nov;40(5):662–670. [PubMed] [Google Scholar]
  39. Sherwood J. B., Goldwasser E. A radioimmunoassay for erythropoietin. Blood. 1979 Oct;54(4):885–893. [PubMed] [Google Scholar]
  40. Sherwood J. B., Goldwasser E., Chilcote R., Carmichael L. D., Nagel R. L. Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood. 1986 Jan;67(1):46–49. [PubMed] [Google Scholar]
  41. Spivak J. L., Barnes D. C., Fuchs E., Quinn T. C. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA. 1989 Jun 2;261(21):3104–3107. [PubMed] [Google Scholar]
  42. Spivak J. L., Hogans B. B. The in vivo metabolism of recombinant human erythropoietin in the rat. Blood. 1989 Jan;73(1):90–99. [PubMed] [Google Scholar]
  43. Spivak J. L., Pham T., Isaacs M., Hankins W. D. Erythropoietin is both a mitogen and a survival factor. Blood. 1991 Mar 15;77(6):1228–1233. [PubMed] [Google Scholar]
  44. Sun C. H., Ward H. J., Paul W. L., Koyle M. A., Yanagawa N., Lee D. B. Serum erythropoietin levels after renal transplantation. N Engl J Med. 1989 Jul 20;321(3):151–157. doi: 10.1056/NEJM198907203210304. [DOI] [PubMed] [Google Scholar]
  45. Urabe A., Takaku F., Mizoguchi H., Kubo K., Ota K., Shimizu N., Tanaka K., Mimura N., Nihei H., Koshikawa S. Effect of recombinant human erythropoietin on the anemia of chronic renal failure. Int J Cell Cloning. 1988 May;6(3):179–191. doi: 10.1002/stem.5530060304. [DOI] [PubMed] [Google Scholar]
  46. Wagemaker G., Visser T. P. Erythropoietin-independent regeneration of erythroid progenitor cells following multiple injections of hydroxyurea. Cell Tissue Kinet. 1980 Sep;13(5):505–517. doi: 10.1111/j.1365-2184.1980.tb00491.x. [DOI] [PubMed] [Google Scholar]
  47. Wide L., Bengtsson C., Birgegård G. Circadian rhythm of erythropoietin in human serum. Br J Haematol. 1989 May;72(1):85–90. doi: 10.1111/j.1365-2141.1989.tb07657.x. [DOI] [PubMed] [Google Scholar]
  48. Winearls C. G., Oliver D. O., Pippard M. J., Reid C., Downing M. R., Cotes P. M. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986 Nov 22;2(8517):1175–1178. doi: 10.1016/s0140-6736(86)92192-6. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES